This week we highlight the integration of artificial intelligence in regulatory compliance for software as a medical device (SaMD), alongside a surge in health care mergers and acquisitions totaling over $6.4 billion. We also examine the U.S. Food and Drug Administration’s approval of Florida's drug ... READ MORE >